ArticleJournal of experimental & clinical cancer research : CR2025

SGSS05-NS3, a covalent SETD8 inhibitor that activates p53 pathway in neuroblastoma.

Zhihui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.